Kalos Management, Inc. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 131 filers reported holding MIRATI THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.

Quarter-by-quarter ownership
Kalos Management, Inc. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$252,000
+8.6%
8,250
-34.3%
0.11%
+4.6%
Q4 2017$232,000
+58.9%
12,550
+0.4%
0.11%
+16.0%
Q3 2017$146,000
+186.3%
12,500
-10.7%
0.09%
+100.0%
Q2 2017$51,00014,0000.05%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,000,000$31,470,0008.67%
Baker Brothers Advisors 2,805,074$88,276,0000.77%
Broadfin Capital, LLC 359,661$11,319,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 397,660$12,514,0000.42%
Boulegeris Investments, Inc. 17,415$548,0000.39%
SPHERA FUNDS MANAGEMENT LTD. 95,000$2,990,0000.29%
Rhenman & Partners Asset Management AB 50,000$1,574,0000.19%
Integre Asset Management, LLC 23,996$755,0000.16%
Orbimed Advisors 680,500$21,415,0000.16%
EAM Investors, LLC 38,754$1,220,0000.14%
View complete list of MIRATI THERAPEUTICS INC shareholders